Description

Survodutide Peptide for Advanced GLP-1 and Glucagon Receptor Signaling Research.

Survodutide Peptide, also designated BI 456906, is an investigational dual incretin receptor agonist developed from a modified glucagon scaffold designed to simultaneously activate GLP-1 receptors (GLP-1R) and glucagon receptors (GCGR). The peptide incorporates structural amino acid modifications and a C18 fatty diacid side chain that promotes reversible albumin binding, enabling prolonged receptor exposure in experimental pharmacokinetic models.

Researchers employ Survodutide Peptide in molecular biology, receptor pharmacology, endocrinology, peptide chemistry, metabolic biology, and cellular signaling studies. Published investigations evaluate dual receptor activation, intracellular second messenger signaling, receptor trafficking, ligand-binding kinetics, cyclic AMP production, glucose-regulated signaling, lipid metabolism, mitochondrial bioenergetics, and endocrine communication.

Unlike selective GLP-1 receptor agonists, Survodutide provides an experimental platform for examining coordinated GLP-1R and GCGR activation within the same molecular framework, allowing researchers to investigate receptor crosstalk, downstream signaling integration, and pharmacodynamic interactions under controlled laboratory conditions.

Each batch is synthesized using stringent quality-controlled manufacturing procedures, analytically verified through chromatographic and mass spectrometric analysis, and supplied as a stable lyophilized peptide with a comprehensive Certificate of Analysis to ensure reproducible laboratory investigations.

For research use only. Not intended for human consumption or clinical use.

Key Research Highlights

• Synthetic dual GLP-1R and GCGR receptor agonist
• Modified 29-amino-acid glucagon analog
• C18 fatty diacid lipidation for prolonged pharmacokinetic studies
• Extensively investigated in incretin receptor biology
• Suitable for receptor pharmacology and metabolic signaling research
• Evaluated in intracellular cAMP signaling studies
• Investigated in endocrine and peptide biology laboratory models
• High-purity research-grade lyophilized peptide
• Certificate of Analysis (COA) included with every batch
• Manufactured under stringent analytical quality standards
• Excellent batch-to-batch reproducibility
• Intended exclusively for laboratory investigations

Why Researchers Choose This Product

• ≥98% purity verified by HPLC and mass spectrometry
• Verified BI 456906 reference sequence
• Stable lyophilized formulation for laboratory storage
• Comprehensive Certificate of Analysis supplied
• Verified structural identity and lipidation
• Reliable analytical consistency across production batches
• Suitable for metabolic biology and receptor pharmacology research
• Manufactured using rigorous peptide synthesis protocols
• Trusted by biotechnology, pharmaceutical, and academic laboratories
• Designed exclusively for scientific research applications

Research Applications

GLP-1 Receptor Biology

Survodutide Peptide is extensively utilized in laboratory investigations examining GLP-1 receptor activation, receptor trafficking, intracellular signaling, ligand-binding kinetics, and receptor pharmacology.

Glucagon Receptor Research

Researchers employ Survodutide to investigate glucagon receptor activation, cyclic AMP signaling, cellular metabolism, receptor regulation, and downstream transcriptional responses.

Dual Incretin Signaling

Experimental models utilize Survodutide to study coordinated GLP-1R and GCGR activation, receptor crosstalk, signaling integration, and pharmacodynamic interactions.

Metabolic Biology

Scientists investigate intracellular pathways regulating glucose metabolism, lipid metabolism, mitochondrial bioenergetics, AMP-activated protein kinase (AMPK), and endocrine signaling.

Molecular Pharmacology

Laboratory investigations incorporate Survodutide into studies evaluating receptor affinity, ligand efficacy, signal amplification, intracellular messenger systems, and peptide pharmacodynamics.

Peptide Chemistry

Researchers utilize Survodutide for analytical characterization, lipidation studies, formulation development, stability testing, recombinant peptide analysis, and structure-activity relationship investigations.

Product Specifications

Mechanism of Action

Survodutide Peptide (BI 456906) is a synthetic dual receptor agonist engineered to activate both the glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR). Derived from a modified glucagon peptide scaffold, the molecule incorporates strategic amino acid substitutions together with a C18 fatty diacid lipidation that promotes reversible albumin binding, extending its pharmacokinetic profile for laboratory investigations of prolonged receptor engagement.

Following receptor binding, Survodutide activates Class B G protein-coupled receptors (GPCRs) expressed on multiple metabolically active tissues. Activation of GLP-1R and GCGR primarily stimulates Gs protein signaling, resulting in increased intracellular adenylyl cyclase activity and elevated cyclic adenosine monophosphate (cAMP) production. This second messenger initiates downstream activation of protein kinase A (PKA), exchange protein directly activated by cAMP (Epac), and additional signaling networks that regulate transcriptional activity, cellular metabolism, and endocrine communication.

Published laboratory investigations have also examined downstream signaling involving CREB, AMP-activated protein kinase (AMPK), PI3K/Akt, MAPK/ERK, and mitochondrial metabolic pathways. Researchers utilize Survodutide to investigate receptor internalization, ligand-receptor kinetics, intracellular trafficking, receptor recycling, and the integration of simultaneous GLP-1R and GCGR signaling within cellular systems.

The lipidated structure contributes to prolonged receptor occupancy through reversible serum albumin association, enabling detailed pharmacokinetic and pharmacodynamic studies of sustained receptor activation. Experimental investigations also evaluate receptor bias, signal amplification, desensitization mechanisms, and differential downstream pathway activation under controlled laboratory conditions.

Its precisely engineered molecular architecture, verified structural integrity, dual receptor pharmacology, and reproducible analytical characteristics have established Survodutide Peptide as a valuable research reagent for endocrinology, receptor pharmacology, peptide chemistry, molecular biology, biotechnology, and life science laboratories investigating incretin biology and dual receptor signaling mechanisms.

For research use only. Not intended for human consumption or clinical use.